Overview
FDC Limited is a leading pharmaceutical company based in India. The company operates primarily in the healthcare and pharmaceutical industry, specializing in the production and distribution of various pharmaceutical products, including prescription medications and over-the-counter drugs. Key projects include the manufacturing of APIs (Active Pharmaceutical Ingredients) and FDFs (Finished Dosage Forms) for both domestic and international markets. FDC Limited is particularly known for its flagship brands like Zifi, Electral, Enerzal, and Vitcofol. The company continues to invest in research and development to innovate and expand its product portfolio, ensuring it remains competitive in the rapidly evolving pharmaceutical industry.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for FDC Limited as of 30 June 2025 is 21,182.57 MM.
- The operating income for FDC Limited as of 30 June 2025 is 2,609.10 MM.
- The net income for FDC Limited as of 30 June 2025 is 2,691.05 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 21,182.57 | 2,609.10 | 2,691.05 |
2025-03-31 | 21,081.20 | 2,710.66 | 2,667.88 |
2024-12-31 | 20,782.64 | 2,765.63 | 2,743.98 |
2024-09-30 | 20,723.19 | 3,116.68 | 3,165.91 |
2024-06-30 | 20,448.36 | 3,218.46 | 3,143.70 |
2024-03-31 | 19,429.44 | 2,986.21 | 3,052.23 |
2023-12-31 | 19,157.14 | 2,994.05 | 2,896.55 |
2023-09-30 | 18,668.43 | 2,649.68 | 2,511.68 |
2023-06-30 | 18,254.65 | 2,557.63 | 2,331.87 |
2023-03-31 | 17,837.50 | 2,120.35 | 1,940.37 |
2022-12-31 | 16,899.97 | 1,753.61 | 1,737.69 |
2022-09-30 | 16,224.82 | 1,747.47 | 1,687.14 |
2022-06-30 | 15,751.12 | 1,791.18 | 1,892.72 |
2022-03-31 | 15,279.19 | 2,163.85 | 2,164.03 |
2021-12-31 | 15,002.68 | 2,478.80 | 2,522.31 |
2021-09-30 | 14,987.17 | 2,736.52 | 2,917.87 |
2021-06-30 | 14,724.93 | 3,080.08 | 3,074.95 |
2021-03-31 | 13,332.03 | 2,962.43 | 3,013.46 |
2020-12-31 | 13,531.36 | 3,130.73 | 3,105.57 |
2020-09-30 | 13,341.27 | 3,240.67 | 3,094.34 |
2020-06-30 | |||
2020-03-31 |
Income Statement: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | 16.73 | 16.73 |
2024-09-30 | 19.46 | 19.46 |
2024-06-30 | 19.23 | 19.23 |
2024-03-31 | 18.59 | 18.59 |
2023-12-31 | 17.71 | 17.71 |
2023-09-30 | 15.16 | 15.16 |
2023-06-30 | 14.04 | 14.04 |
2023-03-31 | 11.67 | 11.67 |
2022-12-31 | 10.41 | 10.41 |
2022-09-30 | 10.06 | 10.06 |
2022-06-30 | 11.23 | 11.23 |
2022-03-31 | 12.82 | 12.82 |
2021-12-31 | 14.91 | 14.91 |
2021-09-30 | 17.27 | 17.27 |
2021-06-30 | 18.15 | 18.15 |
2021-03-31 | 17.73 | 17.73 |
2020-12-31 | 18.21 | 18.20 |
2020-09-30 | 18.04 | 18.04 |
2020-06-30 | 16.08 | 16.08 |
2020-03-31 | 13.94 | 13.94 |
Cash Flow: Operations, Investing, Financing
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | |||
2025-03-31 | 3,175.74 | -1,995.14 | -921.23 |
2024-12-31 | |||
2024-09-30 | 3,202.37 | -2,872.69 | -108.58 |
2024-06-30 | |||
2024-03-31 | 2,207.67 | -170.83 | -2,021.57 |
2023-12-31 | |||
2023-09-30 | 2,142.88 | -84.09 | -2,025.07 |
2023-06-30 | |||
2023-03-31 | 1,549.13 | 111.35 | -1,799.50 |
2022-12-31 | |||
2022-09-30 | 655.38 | 1,092.65 | -1,798.95 |
2022-06-30 | |||
2022-03-31 | 1,616.52 | -1,445.67 | -98.37 |
2021-12-31 | |||
2021-09-30 | 2,421.62 | -1,197.61 | -1,274.75 |
2021-06-30 | |||
2021-03-31 | 2,070.82 | -771.54 | -1,293.49 |
2020-12-31 | |||
2020-09-30 | 2,267.04 | -1,917.86 | -241.44 |
2020-06-30 | |||
2020-03-31 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- The p/e for FDC Limited as of 30 June 2025 is 29.69.
- The p/book for FDC Limited as of 30 June 2025 is 3.47.
- The p/tbv for FDC Limited as of 30 June 2025 is 3.48.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 29.69 | 3.47 | 3.48 |
2025-03-31 | 22.97 | 2.75 | 2.75 |
2024-12-31 | 25.45 | 3.52 | 3.52 |
2024-09-30 | 27.96 | 4.19 | 4.20 |
2024-06-30 | 24.67 | 3.59 | 3.60 |
2024-03-31 | 23.86 | 3.51 | 3.51 |
2023-12-31 | 28.29 | 3.60 | 3.61 |
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | 17.19 | 2.27 | 2.28 |
2021-12-31 | 36.51 | 4.83 | 4.84 |
2021-09-30 | 31.56 | 4.83 | 4.84 |
2021-06-30 | 29.94 | 5.31 | 5.32 |
2021-03-31 | 30.56 | 5.31 | 5.32 |
2020-12-31 | 29.65 | 5.33 | 5.35 |
2020-09-30 | 30.14 | 5.40 | 5.42 |
2020-06-30 | 33.87 | 6.03 | 6.05 |
2020-03-31 | 38.88 | 6.03 | 6.05 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
- The ebit/ev for FDC Limited as of 30 June 2025 is 0.05.
- The ebit (3y)/ev for FDC Limited as of 30 June 2025 is 0.05.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | 0.05 | 0.05 |
2025-03-31 | 0.06 | 0.05 |
2024-12-31 | 0.05 | 0.04 |
2024-09-30 | 0.05 | 0.04 |
2024-06-30 | 0.05 | 0.04 |
2024-03-31 | 0.05 | 0.05 |
2023-12-31 | 0.05 | 0.04 |
2023-09-30 | 0.05 | 0.05 |
2023-06-30 | 0.04 | 0.06 |
2023-03-31 | 0.06 | 0.07 |
2022-12-31 | 0.05 | 0.07 |
2022-09-30 | 0.06 | 0.08 |
2022-06-30 | 0.07 | 0.09 |
2022-03-31 | 0.08 | 0.08 |
2021-12-31 | 0.04 | 0.04 |
2021-09-30 | 0.04 | 0.04 |
2021-06-30 | 0.04 | 0.04 |
2021-03-31 | 0.04 | 0.03 |
2020-12-31 | 0.04 | 0.03 |
2020-09-30 | 0.04 | 0.03 |
2020-06-30 | 0.04 | 0.03 |
2020-03-31 | 0.03 | 0.03 |
Management Effectiveness
- The roa for FDC Limited as of 30 June 2025 is 0.11.
- The roe for FDC Limited as of 30 June 2025 is 0.13.
- The roic for FDC Limited as of 30 June 2025 is 0.12.
- The croic for FDC Limited as of 30 June 2025 is 0.01.
- The ocroic for FDC Limited as of 30 June 2025 is 0.14.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | 0.11 | 0.13 | 0.12 | 0.01 | 0.14 |
2025-03-31 | 0.12 | 0.14 | 0.12 | 0.01 | 0.14 |
2024-12-31 | 0.14 | 0.14 | 0.14 | 0.01 | 0.14 |
2024-09-30 | 0.13 | 0.16 | 0.15 | 0.00 | 0.10 |
2024-06-30 | 0.15 | 0.14 | 0.00 | 0.10 | |
2024-03-31 | 0.13 | 0.15 | 0.15 | 0.00 | 0.11 |
2023-12-31 | 0.11 | 0.13 | 0.13 | 0.00 | 0.11 |
2023-09-30 | 0.10 | 0.12 | 0.12 | 0.00 | 0.00 |
2023-06-30 | 0.08 | 0.12 | 0.12 | -0.01 | 0.08 |
2023-03-31 | 0.08 | 0.10 | 0.10 | -0.01 | 0.08 |
2022-12-31 | 0.08 | 0.09 | 0.09 | -0.00 | 0.03 |
2022-09-30 | 0.09 | 0.09 | 0.09 | -0.00 | 0.03 |
2022-06-30 | 0.11 | 0.11 | 0.10 | 0.00 | 0.08 |
2022-03-31 | 0.13 | 0.12 | 0.11 | 0.00 | 0.08 |
2021-12-31 | 0.15 | 0.15 | 0.13 | -0.00 | 0.13 |
2021-09-30 | 0.15 | 0.17 | 0.15 | -0.00 | 0.00 |
2021-06-30 | 0.17 | 0.20 | 0.18 | 0.00 | 0.12 |
2021-03-31 | 0.17 | 0.19 | 0.17 | 0.00 | 0.12 |
2020-12-31 | 0.18 | 0.22 | 0.18 | 0.01 | 0.13 |
2020-09-30 | 0.18 | 0.22 | 0.18 | 0.01 | 0.13 |
2020-06-30 | 0.17 | 0.19 | 0.18 | 0.01 | 0.16 |
2020-03-31 | 0.15 | 0.17 | 0.15 | 0.01 | 0.16 |
Gross Margins
- The gross margin for FDC Limited as of 30 June 2025 is 0.65.
- The net margin for FDC Limited as of 30 June 2025 is 0.13.
- The operating margin for FDC Limited as of 30 June 2025 is 0.13.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | 0.65 | 0.13 | 0.13 |
2025-03-31 | 0.63 | 0.13 | 0.13 |
2024-12-31 | 0.64 | 0.15 | 0.15 |
2024-09-30 | 0.66 | 0.15 | 0.16 |
2024-06-30 | 0.66 | 0.16 | 0.15 |
2024-03-31 | 0.64 | 0.15 | 0.16 |
2023-12-31 | 0.63 | 0.13 | 0.14 |
2023-09-30 | 0.64 | 0.13 | 0.14 |
2023-06-30 | 0.61 | 0.13 | 0.14 |
2023-03-31 | 0.61 | 0.11 | 0.12 |
2022-12-31 | 0.62 | 0.10 | 0.11 |
2022-09-30 | 0.64 | 0.10 | 0.11 |
2022-06-30 | 0.65 | 0.12 | 0.11 |
2022-03-31 | 0.65 | 0.14 | 0.14 |
2021-12-31 | 0.65 | 0.17 | 0.17 |
2021-09-30 | 0.68 | 0.19 | 0.18 |
2021-06-30 | 0.68 | 0.21 | 0.21 |
2021-03-31 | 0.67 | 0.23 | 0.22 |
2020-12-31 | 0.68 | 0.23 | 0.23 |
2020-09-30 | 0.69 | 0.23 | 0.24 |
2020-06-30 | 0.68 | 0.21 | 0.22 |
2020-03-31 | 0.68 | 0.18 | 0.20 |
Identifiers and Descriptors
Central Index Key (CIK) |
Industry Groups
SIC 2834 - Pharmaceutical Preparations |